title: Risperidone-induced acromegaly: a case report.
abstract: Today, considering their adverse side effects, the first-generation antipsychotics have been replaced by the new-generation antipsychotics (also known as second-generation antipsychotic agents). The superiority of new-generation antipsychotics compared with first-generation antipsychotic agents in terms of side effects, especially movement disorders, are acknowledged by clinicians. But in recent years during the use of second-generation antipsychotic agents, endocrine side effects have been noteworthy. In our study with a diagnosis of paranoid schizophrenia treated with risperidone for 14 years and operated with the diagnosis of pituitary macroadenoma, a 32-year-old female patient is presented in the light of the literature examining the framework of the history of disease.
authors: Ayşe
authors: A
authors: Koroglu
authors: Cicek
authors: C
authors: Hocaoglu
keywords: acromegaly; endocrine side effects; risperidone
references: Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:53-67
references: 12504072
references: CNS Drugs. 2005;19 Suppl 1:1-93
references: 15998156
references: Pharmacotherapy. 2006 Jun;26(6):748-58
references: 16716128
references: Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):369-76
references: 20453648
references: Neurosurg Focus. 2010 Oct;29(4):E2
references: 20887127
references: Eur Neuropsychopharmacol. 2008 May;18 Suppl 2:S108-14
references: 18346598
references: Neurol Sci. 2008 Sep;29(4):289-90
references: 18810608
references: J Clin Endocrinol Metab. 2005 Jul;90(7):4081-6
references: 15886256
references: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006626
references: 21249678
references: Dialogues Clin Neurosci. 2010;12(3):345-57
references: 20954430
references: Eur J Endocrinol. 2005 Dec;153(6):737-40
references: 16322377
references: J Clin Invest. 2009 Nov;119(11):3189-202
references: 19884662
references: Pharmacol Ther. 2010 Sep;127(3):210-51
references: 20493213
references: J Clin Endocrinol Metab. 2004 Feb;89(2):667-74
references: 14764779
references: Ann Gen Psychiatry. 2009 Feb 11;8:5
references: 19210771
references: Actas Esp Psiquiatr. 2009 Nov-Dec;37(6):330-42
references: 20066585
references: Fundam Clin Pharmacol. 2010 Apr;24(2):139-60
references: 19702693
references: J Clin Psychiatry. 2002 May;63(5):408-13
references: 12019665
references: Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):350-5
references: 20502324
references: Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):460-6
references: 20717020